4.7 Article

pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 473, Issue 1-2, Pages 203-212

Publisher

ELSEVIER
DOI: 10.1016/j.ijpharm.2014.07.009

Keywords

Inflammatory bowel disease; Nanoparticles; pH-sensitive; PLGA; Eudragit (R); Curcumin

Funding

  1. Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.) (Regis Coco)

Ask authors/readers for more resources

Nano-scaled particles have been found to preferentially accumulate in inflamed regions. Local delivery of anti-inflammatory drugs loaded in nanoparticles to the inflamed colonic site is of great interest for inflammatory bowel disease (IBD) treatment. Curcumin (CC) is an anti-inflammatory local agent, which presents poor ADME properties. Hence, we evaluated, both in vitro and in vivo, the local delivery of CC using pH-sensitive polymeric nanoparticles (NPs) combining both poly(lactide-co-glycolide) acid (PLGA) and a polymethacrylate polymer (Eudragit (R) S100). CC-NPs significantly enhanced CC permeation across Caco-2 cell monolayers when compared to CC in suspension. CC-NPs significantly reduced TNF-alpha secretion by LPS-activated macrophages (J774 cells). In vivo, CC-NPs significantly decreased neutrophil infiltration and TNF-alpha secretion while maintaining the colonic structure similar to the control group in a murine DSS-induced colitis model. Our results support the use of nanoparticles made of PLGA and Eudragit S100 combination for CC delivery in IBD treatment. (C) 2014 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available